The Leucine-Rich Repeat Receptor Kinase BIR2 Is a Negative Regulator of BAK1 in Plant Immunity

详细信息    查看全文

• 作者：Thierry Halter ; Julia Imkampe ; Sara Mazzotta ; Michael Wierzba ; S ; ra Postel ; Christoph B眉cherl ; Christian Kiefer ; Mark Stahl ; Delphine Chinchilla ; Xiaofeng Wang ; Thorsten N眉rnberger ; Cyril Zipfel ; Steven Clouse ; Jan聽Willem Borst ; Sjef Boeren ; Sacco聽C. de聽Vries ; Frans Tax ; Birgit Kemmerling
• 刊名：Current Biology
• 出版年：20 January, 2014
• 年：2014
• 卷：24
• 期：2
• 页码：134-143
• 全文大小：1225 K

文摘

| Figures/TablesFigures/Tables | ReferencesReferences

Summary

Background

Transmembrane leucine-rich repeat (LRR) receptors are commonly used innate immune receptors in plants and animals but can also sense endogenous signals to regulate development. BAK1 is a plant LRR-receptor-like kinase (RLK) that interacts with several ligand-binding LRR-RLKs to聽positively regulate their functions. BAK1 is involved in brassinosteroid-dependent growth and development, innate immunity, and cell-death control by interacting with the brassinosteroid receptor BRI1, immune receptors, such as FLS2 and EFR, and the small receptor kinase BIR1, respectively.

Results

Identification of in聽vivo BAK1 complex partners by LC/ESI-MS/MS uncovered two novel BAK1-interacting RLKs, BIR2 and BIR3. Phosphorylation studies revealed that BIR2 is unidirectionally phosphorylated by BAK1 and that the interaction between BAK1 and BIR2 is kinase-activity dependent. Functional analyses of bir2 mutants show differential impact on BAK1-regulated processes, such as hyperresponsiveness to pathogen-associated molecular patterns (PAMP), enhanced cell death, and resistance to bacterial pathogens, but have no effect on brassinosteroid-regulated growth. BIR2 interacts constitutively with BAK1, thereby preventing interaction with the ligand-binding LRR-RLK FLS2. PAMP perception leads to BIR2 release from the BAK1 complex and enables the recruitment of BAK1 into the FLS2 complex.

Conclusions

Our results provide evidence for a new regulatory mechanism for innate immune receptors with BIR2 acting as a negative regulator of PAMP-triggered immunity by limiting BAK1-receptor complex formation in the absence of ligands.